» Articles » PMID: 21421560

A Type IV Modification-dependent Restriction Enzyme SauUSI from Staphylococcus Aureus Subsp. Aureus USA300

Overview
Specialty Biochemistry
Date 2011 Mar 23
PMID 21421560
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

A gene encoding a putative DNA helicase from Staphylococcus aureus USA300 was cloned and expressed in Escherichia coli. The protein was purified to over 90% purity by chromatography. The purified enzyme, SauUSI, predominantly cleaves modified DNA containing 5mC and 5-hydroxymethylcytosine. Cleavage of 5mC-modified plasmids indicated that the sites S5mCNGS (S = C or G) are preferentially digested. The endonuclease activity requires the presence of adenosine triphosphate (ATP) or dATP whereas the non-hydrolyzable γ-S-ATP does not support activity. SauUSI activity was inhibited by ethylenediaminetetraacetic acid. It is most active in Mg(++) buffers. No companion methylase gene was found near the SauUSI restriction gene. The absence of a cognate methylase and cleavage of modified DNA indicate that SauUSI belongs to type IV restriction endonucleases, a group that includes EcoK McrBC and Mrr. SauUSI belongs to a family of highly similar homologs found in other sequenced S. aureus, S. epidermidis and S. carnosus genomes. More distant SauUSI orthologs can be found in over 150 sequenced bacterial/archaea genomes. Finally, we demonstrated the biological function of the type IV REase in restricting 5mC-modified plasmid DNA by transformation into clinical S. aureus strain SA564, and in restricting phage λ infection when the endonuclease is expressed in E. coli.

Citing Articles

Nucleic acid recognition during prokaryotic immunity.

Baca C, Marraffini L Mol Cell. 2025; 85(2):309-322.

PMID: 39824170 PMC: 11750177. DOI: 10.1016/j.molcel.2024.12.007.


Multiomics analysis of Staphylococcus aureus ST239 strains resistant to virulent Herelleviridae phages.

Kornienko M, Bespiatykh D, Abdraimova N, Gorodnichev R, Gostev V, Boldyreva D Sci Rep. 2024; 14(1):29375.

PMID: 39592862 PMC: 11599779. DOI: 10.1038/s41598-024-80909-x.


Altered genomic methylation promotes Staphylococcus aureus persistence in hospital environment.

Yamazaki Y, Ito T, Nakagawa S, Sugihira T, Kurita-Tachibana C, Villaruz A Nat Commun. 2024; 15(1):9619.

PMID: 39511195 PMC: 11544029. DOI: 10.1038/s41467-024-54033-3.


An enterococcal phage protein inhibits type IV restriction enzymes involved in antiphage defense.

Bullen N, Johnson C, Andersen S, Arya G, Marotta S, Lee Y Nat Commun. 2024; 15(1):6955.

PMID: 39138193 PMC: 11322646. DOI: 10.1038/s41467-024-51346-1.


An enterococcal phage protein broadly inhibits type IV restriction enzymes involved in antiphage defense.

Bullen N, Johnson C, Andersen S, Arya G, Marotta S, Lee Y bioRxiv. 2023; .

PMID: 38014348 PMC: 10680825. DOI: 10.1101/2023.11.16.567456.


References
1.
Fluit A, Schmitz F . Resistance integrons and super-integrons. Clin Microbiol Infect. 2004; 10(4):272-88. DOI: 10.1111/j.1198-743X.2004.00858.x. View

2.
Waldron D, Lindsay J . Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol. 2006; 188(15):5578-85. PMC: 1540015. DOI: 10.1128/JB.00418-06. View

3.
Fineran P, Blower T, Foulds I, Humphreys D, Lilley K, Salmond G . The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc Natl Acad Sci U S A. 2009; 106(3):894-9. PMC: 2630095. DOI: 10.1073/pnas.0808832106. View

4.
Weigel L, Donlan R, Shin D, Jensen B, Clark N, McDougal L . High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother. 2006; 51(1):231-8. PMC: 1797660. DOI: 10.1128/AAC.00576-06. View

5.
Sayers E, Barrett T, Benson D, Bryant S, Canese K, Chetvernin V . Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2008; 37(Database issue):D5-15. PMC: 2686545. DOI: 10.1093/nar/gkn741. View